SMO and embryonal rhabdomyosarcoma: Indeed, the three SMO inhibitors vismodegib, sonidegib, and HhAntag strongly downregulated Gli1 expression in Ptch mutant ERMS cells both in vitro and in vivo and strongly induced antiproliferative effects in vivo.